对药剂师在痴呆症咨询中的心理测量评估
1Department of Pharmacy Management, Izmir Katip Celebi University Faculty of Pharmacy, Izmir, Turkiye.
Patient education and counseling
|July 28, 2023
概括
药剂师对痴呆症咨询表现出积极的态度和意图. 基于计划行为理论的新测量工具被开发和验证,用于评估药剂师的行为.
科学领域:
- 药房实践 在药房实践中
- 行为科学 行为科学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 痴呆症护理需要有效的药剂师咨询.
- 了解药剂师的态度和意图对于改善痴呆症护理至关重要.
- 计划行为理论为预测行为提供了一个框架.
研究的目的:
- 开发和验证药剂师关于痴呆症的咨询行为的测量工具.
- 探索药剂师的态度,主观规范和与痴呆症咨询相关的意图.
- 评估开发的测量工具的心理特征.
主要方法:
- 对190名社区药剂师进行的在线调查.
- 使用了探索性因素分析 (EFA) 和确认性因素分析 (CFA).
- 曼-惠特尼U测试用于比较组.
主要成果:
- 证实了六个因素结构,解释了71.294%的差异.
- 可靠性 (克朗巴赫的α) 范围从0.728到0.913.
- 药剂师报告了对痴呆症咨询的积极态度和意图,根据痴呆症特定培训指出了差异.
结论:
- 开发的测量工具证明了令人满意的构造有效性,可靠性和区分有效性.
- 该工具适用于调查药剂师自我报告的痴呆症咨询.
- 这些发现支持这种工具用于各种健康状况和药剂师咨询行为的应用.
相关概念视频
01:30Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
01:26Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
155
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
155
01:22Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
01:22Self-Report Tests of Personality
381
Self-report inventories are objective personality assessments that use multiple-choice items or numbered scales, typically ranging from 1 (strongly disagree) to 5 (strongly agree). They are often called Likert scales after Rensis Likert. These inventories are widely used due to their ease of administration and cost-effectiveness. One of the most prominent examples is the Minnesota Multiphasic Personality Inventory (MMPI), initially developed in the 1940s to assess abnormal personality traits.
381
01:28Drug Therapy
71
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
71